The knowledge of antimicrobial resistance: a survey in the community pharmacies of north-west Italy
Main Article Content
Keywords
AntiMicrobial Resistance, questionnaire, information campaign, community pharmacies, AMR
Abstract
Background: Antimicrobial Resistance (AMR) occurs in nature, but the inappropriate and excessive use of antimicrobials, and poor infection prevention, have all contributed to the increasing incidence of this phenomenon. As a result of AMR, infections become harder to treat, spread more easily and cause more severe illness and deaths. Objective: Community pharmacies, thanks to their widespread distribution, local accessibility and extended opening hours, could play a significant role in the fight against AMR. To test this hypothesis we designed the present study with two objectives. Firstly, to evaluate AMR knowledge and behaviours in a sample of community pharmacy customers in the northwest of Piedmont. Secondly, to obtain information to understand the potential role of the pharmacist. Methods: A survey to evaluate the AMR knowledge and behaviours of pharmacy customers was carried out. The work was designed as a survey. Data was collected in 2020-2021 in 46 pharmacies by means of a face-to-face interview using a questionnaire. Each pharmacist attended a training course regarding the administration of the questionnaire to avoid any bias. The course also aimed to enhance pharmacists’ communication skills to give evidence-based AMR-related advice to customers. Results: 1,883 subjects were interviewed. The investigation showed that there was a significant lack of awareness of AMR among the study population. Only 36.59% of respondents were able to identify the correct definition of this term, the rest of the interviewees had little or no knowledge of the problem and the consequences of this condition. The results also suggest that a health education programme might be helpful in achieving significant results: in the sample, those who demonstrated a previous knowledge of the phenomenon, also demonstrated the best behaviour. Conclusions: Community pharmacists could be a useful resource for assessing and improving AMR knowledge and behaviour and potentially take an active role in enhancing information campaigns. This is especially important for elderly populations who are the least informed and are the main users of community pharmacies.
References
2. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277-283.
3. European Centre for Disease Prevention and Control. Antimicrobial Resistance: Tackling the Burden in the European Union. 2019. Available online: https://www.oecd.org/health/health-systems/AMR-Tackling-the-Burden-in-the-EU-OECD-ECDC-Briefing-Note-2019.pdf.
4. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2019. Available online: https://stacks.cdc.gov/view/cdc/82532. Accessed 2024 Jun 1.
5. European Centre for Disease Prevention and Control. Antimicrobial Resistance in the EU/EEA - A One Health response. 2022. Available online: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-eueea-one-health-response. Accessed 2024 Jun 1.
6. Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. Molecules. 2018;23(4):795. Published 2018 Mar 30. doi:10.3390/molecules23040795.
7. Maron DF, Smith TJ, Nachman KE. Restrictions on antimicrobial use in food animal production: an international regulatory and economic survey. Global Health. 2013;9:48. Published 2013 Oct 16. doi:10.1186/1744-8603-9-48.
8. Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect Drug Resist. 2019;12:3903-3910. Published 2019 Dec 20. doi:10.2147/IDR.S234610.
9. World Health Organization. Global action plan on antimicrobial resistance. 2015. Available online: https://www.who.int/publications/i/item/9789241509763. Accessed 2024 Jun 1.
10. Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29-38. doi:10.1111/bcp.14164.
11. Solidoro P, Braido F, Baratta F, et al. FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies. Panminerva Med. 2013;55(1):87-92.
12. Giaccone M, Baratta F, Allais G, Brusa P. Prevention, education and information: the role of the community pharmacist in the management of headaches. Neurol Sci. 2014;35 Suppl 1:1-4. doi:10.1007/s10072-014-1732-6.
13. Brusa P, Allais G, Rolando S, et al. Migraine attacks in the pharmacy: a gender subanalysis on treatment preferences. Neurol Sci. 2015;36 Suppl 1:93-95. doi:10.1007/s10072-015-2156-7.
14. Brusa P, Parente M, Allais G, et al. Community pharmacies as epidemiological sentinels of headache: first experience in Italy. Neurol Sci. 2017;38(Suppl 1):15-20. doi:10.1007/s10072-017-2908-7.
15. Baratta F, Allais G, Rolando S, et al. Prevention, education and counselling: the worldwide role of the community pharmacist as an epidemiological sentinel of headaches. Neurol Sci. 2019;40(Suppl 1):15-21. doi:10.1007/s10072-019-03794-7.
16. Brusa P, Allais G, Scarinzi C, et al. Self-medication for migraine: A nationwide cross-sectional study in Italy. PLoS One. 2019;14(1) Published 2019 Jan 23. doi:10.1371/journal.pone.0211191.
17. Pappaccogli M, Ravetto Enri L, Perlo E, et al. Assessment of a non-physician screening program for hypertension and cardiovascular risk in community pharmacies. Nutr Metab Cardiovasc Dis. 2019;29(12):1316-1322. doi:10.1016/j.numecd.2019.07.009.
18. Gnavi R, Sciannameo V, Baratta F, et al. Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy. PLoS One. 2020;15(3) Published 2020 Mar 18. doi:10.1371/journal.pone.0229842.
19. Fanelli E, Ravetto Enri L, Pappaccogli M, et al. Knowledge on arterial hypertension in general population: Results from a community pharmacy screening program. Nutr Metab Cardiovasc Dis. 2021;31(4):1081-1086. doi:10.1016/j.numecd.2021.01.004.
20. Higher Institute of Health. EpiCentro - Epidemiology for public health. Pharmacists for health. 2020. Available online: https://www.epicentro.iss.it/guadagnare-salute/comunicazione/farmacisti. Accessed 2024 Jun 1.
21. World Health Organization. Antibiotic Resistance: Multi-country public awareness survey. 2016. Available online: https://apps.who.int/iris/bitstream/handle/10665/194460/9789241509817_eng.pdf?sequence=1; 2016. Accessed 2024 Jun 1.
22. Prigitano A, Romanò L, Auxilia F, Castaldi S, Tortorano AM. Antibiotic resistance: Italian awareness survey 2016. J Infect Public Health. 2018;11(1):30-34. doi:10.1016/j.jiph.2017.02.010.
23. Baratta F, Pignata I, Vicenzi G, et al. Oncological patient management on the territory: the results of a survey in the north-west of Italy. Pharm Pract (Granada). 2022;20(4):2716. doi:10.18549/PharmPract.2022.4.2716.
24. Baratta F, Ciccolella M, Brusa P. The Relationship between Customers and Community Pharmacies during the COVID-19 (SARS-CoV-2) Pandemic: A Survey from Italy. Int J Environ Res Public Health. 2021;18(18):9582. Published 2021 Sep 11. doi:10.3390/ijerph18189582.
25. Parente M, Pignata I, Gnavi R, et al. Assessment of Non-Adherence to Oral Metformin and Atorvastatin Therapies: A Cross-Sectional Survey in Piedmont (Italy). Patient Prefer Adherence. 2020;14:261-266. Published 2020 Feb 14. doi:10.2147/PPA.S226206.
26. Spadea T, Onorati R, Baratta F, et al. Monitoring adherence to pharmacological therapy and follow-up examinations among patients with type 2 diabetes in community pharmacies. Results from an experience in Italy. PLoS One. 2021;16(9) Published 2021 Sep 7. doi:10.1371/journal.pone.0256478.
27. Spadea T, Scarinzi C, Baratta F, et al. Access to migraine centres by educational level of patients and awareness of the disease. Neurol Sci. 2019;40(Suppl 1):207-209. doi:10.1007/s10072-019-03819-1.
28. Ravetto Enri L, Baratta F, Pignata I, Brusa P. How to promote vaccinations: a pilot study in the North-West of Italy. Hum Vaccin Immunother. 2019;15(5):1075-1079. doi:10.1080/21645515.2019.1581540.
29. Baratta F, Enri LR, Brusa P. Community pharmacists as vaccinators in the Italian SARS-CoV-2 immunization campaign: implications beyond the pandemic. Health Policy. 2023;131:104798. doi:10.1016/j.healthpol.2023.104798.
30. Shehadeh MB, Suaifan GA, Hammad EA. Active educational intervention as a tool to improve safe and appropriate use of antibiotics. Saudi Pharm J. 2016;24(5):611-615. doi:10.1016/j.jsps.2015.03.025.
31. Presidency of the Council of Ministers - Polygraphic Institute and State Mint. Decreto Legislativo 3 Ottobre 2009, n. 153 “Individuazione di nuovi servizi erogati dalle farmacie nell’ambito del Servizio sanitario nazionale, nonché’ disposizioni in materia di indennità di residenza per i titolari di farmacie rurali, a norma dell’articolo 11 della legge 18 giugno 2009, n. 69” 2009. Available online: https://www.normattiva.it/atto/caricaDettaglioAtto?atto.dataPubblicazioneGazzetta=2009-1104&atto.codiceRedazionale=009G0162&atto.articolo.numero=0&atto.articolo.sottoArticolo=1&atto.articolo.sottoArticolo1=10&qId=&tabID=0.11519462833425986&title=lbl.dettaglioAtto; 2009. Accessed 2024 Jun 1.
32. Garante per la protezione dei dati personali. Deliberazione 5 maggio 2011. Linee guida in tema di trattamento di dati per lo svolgimento di indagini di customer satisfaction in ambito sanitario (Guidelines on Processing Personal Data to Perform Customer Satisfaction Surveys in the Health Care Sector). Deliberazione n. 182 - Official Gazette of the Italian Republic n. 120, May 25 (Italian).
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.